Evidence map›Paper›PMID 32274105›Full record

ArticleJournal of thoracic disease2020

Schisandra A ameliorates cigarette smoke extract and lipopolysaccharide-induced oxidative stress in lung epithelial cells.

Dapeng Zhang, Suzhen Hu, Wanyan Li, Ran Ao, Zhijuan Wu, Zhimin Zhang, Ling Han

Open access · diamondAbstract read
In one paragraph

Article in Journal of thoracic disease, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Dapeng ZhangFirst Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, China.
Suzhen HuHuangdao District Chinese Medicine Hospital, Qingdao 266000, China.
Wanyan LiFirst Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, China.
Ran AoFirst Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, China.
Zhijuan WuFirst Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, China.
Zhimin ZhangFirst Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, China.
Ling HanGuangdong Provincial Academy of Chinese Medical Sciences, Guangzhou 510120, China.
First Affiliated Hospital of Guangzhou Medical University · CNGuangzhou Medical University · CNGuangdong Academy of Medical Sciences · CNJimo District Qingdao Hospital of Traditional Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe previous studies reported the antioxidant and anti-inflammatory properties of Schisandrin A (Sch A). This study aimed to investigate the ability of Sch A to protect against lung oxidative stress induced by the combination of cigarette smoke extract and lipopolysaccharide (LPS) in an

methodsThe cell viability was determined by using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Colorimetry was used to detect the changes in antioxidant markers. Quantitative real-time polymerase chain reaction (RT-PCR) was used to examine the mRNA levels of interleukin-8 (IL-8) and heme oxygenase-1 (HO-1). The levels of IL-8 and HO-1 in the supernatant were determined by enzyme-linked immunosorbent assay, and Western blot analysis was performed to measure the phosphorylation and protein expression levels of nuclear factor-κB.

resultsSch A inhibited the excessive proliferation of pulmonary epithelial cells, decreased malondialdehyde content, and increased the expression levels of superoxide dismutase and glutathione after the combined treatment of cigarette smoke extract and LPS. Also, Sch A downregulated the expression of IL-8 and upregulated the expression of HO-1 mRNA in lung epithelial cells and cell supernatants, and resulted in the downregulation of the protein expression level of phosphorylated nuclear factor-κB.

conclusionsSch A inhibited the oxidative stress of lung epithelial cells induced by the combination of cigarette smoke extract and LPS. Sch A may be a potential therapeutic medication for COPD.

Indexed as

Chronic obstructive pulmonary disease (COPD)cigarette smoke extractlipopolysaccharide (LPS)oxidative stressSchisandrin A (Sch A)

Identifiers

PMID32274105
PMCPMC7139085
OpenAlexW3008180292

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.